Microtubule inhibitor chemotherapy drugs market to reach $7.23 billion by 2030 at 5.8% CAGR, driven by increasing prevalence of cancer.
Read More
Microcarrier beads market to reach $4.95 billion by 2030 at 8.9% CAGR, driven by growing trend of personalized medicine.
Read More
Non-hormonal contraceptives market to reach $35.8 billion by 2030 at 7.0% cagr, driven by growing prevalence of sexually transmitted diseases.
Read More
Non-Alcoholic Steatohepatitis Treatment Market Outlook Highlighting Key Drivers And Market Evolution
Non-alcoholic steatohepatitis treatment market to reach $18.97 billion by 2030 at 39.7% cagr, driven by increased prevalence of insulin resistance.
Read More
Non-alcoholic steatohepatitis (nash) market to reach $24.32 billion by 2030 at 31.9% cagr, driven by rising cases of obesity.
Read More
Non hodgkin lymphoma (nhl) market to reach $16.44 billion by 2030 at 8.8% cagr, driven by high prevalence of non-hodgkin lymphoma.
Read More
Nocturnal enuresis medication market to reach $2.26 billion by 2030 at 6.7% cagr, driven by increasing demand for personalized care and rising healthcare expenditure.
Read More
Nivolumab market to reach $3.63 billion by 2030 at 13.8% cagr, driven by increased incidence of non-small cell lung cancer and rising adoption of personalized medicine.
Read More
Nitrogen mustards market to reach $4.65 billion by 2030 at 5.8% cagr, driven by increasing prevalence of cancer and adoption of personalized medicine.
Read More
Nimesulide dispersible tablet market to reach $1.16 billion by 2030 at 7.0% cagr, driven by increasing prevalence of musculoskeletal disorders and chronic pain.
Read More